Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 18
20
Diseases
50
Unique genes
0.257
Avg. similarity score
17q23.1q23.2 microdeletion syndrome
Most-connected disease (11 links)
Disease
Searched: nail-patella syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
nail-patella syndrome
17q23.1q23.2 microdeletion syndrome
Amelia
Chromosome 17q23.1-q23.2 duplication syndrome
Coxopodopatellar syndrome
Ischiocoxopodopatellar syndrome with pulmonary arterial hypertension
Clubfoot
Sacral agenesis
Arthropathy
Congenital hypoplasia of lung
Patellar aplasia
Tetra-amelia syndrome
Congenital clubfoot
Hydronephrosis
Vitamin a deficiency
Bmp4-related ocular growth disorder
ehlers-danlos syndrome, musculocontractural type 1
Kidney atrophy
progressive pseudorheumatoid arthropathy of childhood
progressive retinal dystrophy due to retinol transport defect
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| 17q23.1q23.2 microdeletion syndrome | 11 | 11 | 1 |
| Amelia | 11 | 11 | 1 |
| Chromosome 17q23.1-q23.2 duplication syndrome | 10 | 10 | 1 |
| Coxopodopatellar syndrome | 10 | 10 | 1 |
| Ischiocoxopodopatellar syndrome with pulmonary arterial hypertension | 9 | 9 | 1 |
| Clubfoot | 7 | 7 | 6 |
| Sacral agenesis | 7 | 7 | 4 |
| Arthropathy | 6 | 6 | 3 |
| Congenital hypoplasia of lung | 5 | 5 | 3 |
| Patellar aplasia | 5 | 5 | 2 |
| Tetra-amelia syndrome | 5 | 5 | 4 |
| Congenital clubfoot | 3 | 3 | 23 |
| Hydronephrosis | 3 | 3 | 12 |
| Vitamin a deficiency | 3 | 3 | 5 |
| Bmp4-related ocular growth disorder | 2 | 2 | 1 |
| ehlers-danlos syndrome, musculocontractural type 1 | 2 | 2 | 1 |
| nail-patella syndrome | 2 | 2 | 1 |
| Kidney atrophy | 1 | 1 | 1 |
| progressive pseudorheumatoid arthropathy of childhood | 1 | 1 | 1 |
| progressive retinal dystrophy due to retinol transport defect | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TBX4 | 12 / 20 | 17q23.1q23.2 microdeletion syndrome, Amelia, Arthropathy, Chromosome 17q23.1-q23.2 duplication syndrome and 8 more |
| BMP4 | 3 / 20 | Bmp4-related ocular growth disorder, Sacral agenesis, Vitamin a deficiency |
| CHST14 | 3 / 20 | Clubfoot, Congenital clubfoot, ehlers-danlos syndrome, musculocontractural type 1 |
| LMX1B | 3 / 20 | Clubfoot, Congenital clubfoot, nail-patella syndrome |
| C12ORF57 | 2 / 20 | Hydronephrosis, Kidney atrophy |
| CCN6 | 2 / 20 | Arthropathy, progressive pseudorheumatoid arthropathy of childhood |
| MTHFR | 2 / 20 | Clubfoot, Congenital clubfoot |
| PITX1 | 2 / 20 | Clubfoot, Congenital clubfoot |
| RBP4 | 2 / 20 | progressive retinal dystrophy due to retinol transport defect, Vitamin a deficiency |
| RYR1 | 2 / 20 | Congenital clubfoot, Sacral agenesis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cohesin Loading onto Chromatin | Reactome | 2 / 10 | 48.0× | 7.48e-4 | 1.08e-2 ✓ sig. |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | Reactome | 2 / 12 | 40.0× | 1.09e-3 | 1.44e-2 ✓ sig. |
| Retinoid cycle disease events | Reactome | 2 / 13 | 37.0× | 1.29e-3 | 1.63e-2 ✓ sig. |
| Aminoacyl-tRNA biosynthesis | KEGG | 3 / 66 | 10.9× | 2.58e-3 | 2.75e-2 ✓ sig. |
| The canonical retinoid cycle in rods (twilight vision) | Reactome | 2 / 20 | 24.0× | 3.08e-3 | 3.12e-2 ✓ sig. |
| Mtb iron assimilation by chelation | Reactome | 1 / 1 | 240× | 4.16e-3 | 3.86e-2 ✓ sig. |
| Biosynthesis of EPA-derived SPMs | Reactome | 1 / 1 | 240× | 4.16e-3 | 3.86e-2 ✓ sig. |
| Biosynthesis of DPAn-3 SPMs | Reactome | 1 / 1 | 240× | 4.16e-3 | 3.86e-2 ✓ sig. |
| Retinoid metabolism disease events | Reactome | 1 / 1 | 240× | 4.16e-3 | 3.86e-2 ✓ sig. |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | Reactome | 1 / 2 | 120× | 8.31e-3 | 6.14e-2 |
| ARL13B-mediated ciliary trafficking of INPP5E | Reactome | 1 / 3 | 80.1× | 1.24e-2 | 7.94e-2 |
| Biosynthesis of DHA-derived SPMs | Reactome | 1 / 3 | 80.1× | 1.24e-2 | 7.94e-2 |
| Retinoid metabolism and transport | Reactome | 2 / 41 | 11.7× | 1.26e-2 | 8.00e-2 |
| Biosynthesis of protectins | Reactome | 1 / 4 | 60.1× | 1.66e-2 | 9.42e-2 |
| Ovarian steroidogenesis | KEGG | 2 / 52 | 9.2× | 1.97e-2 | 1.04e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| embryonic hindlimb morphogenesis | GO:0035116 | 5 / 29 | 64.4× | 1.26e-8 | 2.07e-6 ✓ sig. |
| tRNA aminoacylation | GO:0043039 | 3 / 13 | 86.2× | 5.06e-6 | 3.06e-4 ✓ sig. |
| response to hypoxia | GO:0001666 | 6 / 176 | 12.7× | 7.22e-6 | 4.07e-4 ✓ sig. |
| alanyl-tRNA aminoacylation | GO:0006419 | 2 / 3 | 249× | 2.10e-5 | 9.39e-4 ✓ sig. |
| heart morphogenesis | GO:0003007 | 4 / 61 | 24.5× | 2.11e-5 | 9.44e-4 ✓ sig. |
| eye morphogenesis | GO:0048592 | 2 / 4 | 187× | 4.20e-5 | 1.58e-3 ✓ sig. |
| metanephric ascending thin limb development | GO:0072218 | 2 / 4 | 187× | 4.20e-5 | 1.58e-3 ✓ sig. |
| kidney development | GO:0001822 | 5 / 146 | 12.8× | 4.34e-5 | 1.62e-3 ✓ sig. |
| skeletal system development | GO:0001501 | 5 / 151 | 12.4× | 5.10e-5 | 1.84e-3 ✓ sig. |
| regulation of branching involved in prostate gland morphogenesis | GO:0060687 | 2 / 5 | 149× | 6.98e-5 | 2.32e-3 ✓ sig. |
| regulation of blood pressure | GO:0008217 | 4 / 83 | 18.0× | 7.13e-5 | 2.36e-3 ✓ sig. |
| heart development | GO:0007507 | 6 / 273 | 8.2× | 8.53e-5 | 2.69e-3 ✓ sig. |
| embryonic forelimb morphogenesis | GO:0035115 | 3 / 33 | 34.0× | 9.29e-5 | 2.87e-3 ✓ sig. |
| cartilage development | GO:0051216 | 4 / 89 | 16.8× | 9.36e-5 | 2.89e-3 ✓ sig. |
| digestive tract development | GO:0048565 | 3 / 34 | 33.0× | 1.02e-4 | 3.07e-3 ✓ sig. |